Skip to main content
Fig. 3 | BMC Clinical Pathology

Fig. 3

From: Differential expression of CK20, β-catenin, and MUC2/5AC/6 in Lynch syndrome and familial colorectal cancer type X

Fig. 3

MUC2 expression in a Lynch syndrome carcinoma (a) and in a FCCTX carcinoma (b): 88% of the Lynch syndrome carcinomas were MUC2 positive, compared to 65% of the FCCTX cases. The Lynch syndrome carcinoma illustrated in A, is extensively decorated (portions of non-neoplastic crypts appear to the right). The FCCTX carcinoma, illustrated in B, comprises only few scattered immunopositive cells. Top of the field displays basis of several non-neoplastic crypts

Back to article page

BMC Clinical Pathology

ISSN: 1472-6890

Contact us